Düsseldorf, Germany

Marcus Eichmann

This inventor holds 5 USPTO granted patents. Top assignee: Bayer Materialscience Ag. Active years: 2013-2015.


% Patents Active = 20.0

Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 30(Granted Patents)


Location History:

  • Düsseldorf, DE (2013 - 2014)
  • Dusseldorf, DE (2014 - 2015)

Company Filing History:


Years Active: 2013-2015

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Marcus Eichmann in Polyether Polyols

Introduction

Marcus Eichmann is a notable inventor based in Düsseldorf, Germany. He has made significant contributions to the field of polyether polyols, holding a total of 5 patents. His work focuses on innovative processes that enhance the production of these essential chemical compounds.

Latest Patents

Eichmann's latest patents include a process for preparing polyether polyols through a base-catalyzed addition of alkylene oxides onto solid starter compounds. This process is particularly noteworthy as it yields visually clear and homogeneous products without the need for solvents. Another significant patent involves a solvent-free method for preparing polyether polyols with a blockwise polyether chain structure, also based on solid starter compounds.

Career Highlights

Marcus Eichmann is currently associated with Bayer MaterialScience AG, where he continues to advance his research and development efforts. His innovative approaches have positioned him as a key figure in the field of polyether polyols.

Collaborations

Eichmann has collaborated with esteemed colleagues such as Klaus Lorenz and Arnulf Werner, contributing to a dynamic research environment that fosters innovation.

Conclusion

Marcus Eichmann's contributions to the field of polyether polyols through his innovative patents and collaborative efforts highlight his importance as an inventor. His work continues to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…